Michael Falvey, M.S.M
2018
In 2018, Michael Falvey, M.S.M earned a total compensation of $1.3M as Former Executive Vice President, Chief Financial Officer and Treasurer at Karyopharm Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $173,417 |
|---|---|
| Option Awards | $686,214 |
| Salary | $404,000 |
| Other | $11,660 |
| Total | $1,275,291 |
MSM received $686.2K in option awards, accounting for 54% of the total pay in 2018.
MSM also received $173.4K in non-equity incentive plan, $404K in salary and $11.7K in other compensation.
Rankings
In 2018, Michael Falvey, M.S.M's compensation ranked 7,980th out of 14,244 executives tracked by ExecPay. In other words, MSM earned more than 44.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,980 out of 14,244 | 44th |
Division Manufacturing | 3,138 out of 5,762 | 46th |
Major group Chemicals And Allied Products | 1,171 out of 2,125 | 45th |
Industry group Drugs | 983 out of 1,814 | 46th |
Industry Pharmaceutical Preparations | 763 out of 1,388 | 45th |
Source: SEC filing on April 19, 2019.
MSM's colleagues
We found four more compensation records of executives who worked with Michael Falvey, M.S.M at Karyopharm Therapeutics in 2018.
2018
Anand Varadan
Karyopharm Therapeutics
Executive Vice President, Chief Commercial Officer
2018
Michael Kauffman
Karyopharm Therapeutics
Chief Executive Officer
2018
Sharon Shacham
Karyopharm Therapeutics
Chief Scientific Officer
2018
Christopher Primiano
Karyopharm Therapeutics